Despite not being professional antigen-presenting cells, FLS can also present peptides, such as human cartilage gp-39 and human type II collagen (CII), derived from autoantigens discovered in the joint tissues of patients with RA, to activated T cells in vitro in an IFN-dependent and MHC-restricted manner (42). This evidence concerns the gene IFNA1 and rheumatoid arthritis.